|
|
|
|
A more recent version of this article appeared on April 1, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 3, 2007
Revised on November 28, 2007
Accepted on January 10, 2008
Departments of *Cancer Biology and ¶Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107;
Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC 20057;
Research Institute of Molecular Pathology (IMP), A-1030 Vienna, Austria; ||Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara 630-0101, Japan
Monitoring Editor: John Cleveland
The spread of metastatic tumors to different organs is associated with poor prognosis. The metastatic process requires migration and cellular invasion. The protooncogene c-jun encodes the founding member of the Activator Protein-1 family and is required for cellular proliferation and DNA synthesis in response to oncogenic signals and plays an essential role in chemical carcinogenesis. The role of c-Jun in cellular invasion remains to be defined. Genetic deletion of c-Jun in transgenic mice is embryonic lethal, therefore transgenic mice encoding a c-Jun gene flanked by lox P sites (c-junf/f) were used. c-jun gene deletion reduced c-Src expression, hyperactivated ROCK II signaling, and reduced cellular polarity, migration and invasiveness. c-Jun increased c-Src mRNA abundance and c-Src promoter activity involving an AP-1 site in the c-Src promoter. Transduction of c-jun-/- cells with either c-Jun or c-Src retroviral expression systems restored the defective cellular migration of c-jun-/- cells. As c-Src is a critical component of pathways regulating proliferation, survival and metastasis, the induction of c-Src abundance, by c-Jun, provides a novel mechanism of cooperative signaling in cellular invasion.
These authors contributed equally to this work.
Address correspondence to:
Richard G. Pestell (Richard.Pestell{at}jefferson.edu)